Document ID: chunk:federal_register_of_legislation:F2024L01746:clause:3_1
Version: federal_register_of_legislation:F2024L01746
Segment Type: clause
Provision Reference: sch 3 cl 1
Character Range: 15239–16218

1  Schedule 1 (table)
Omit:
Atropine  Injection containing atropine sulfate monohydrate 600 micrograms in 1 mL  Injection  Atropine Injection (Pfizer)  6 months stock by reference to usual PBS demand

substitute:
Atropine  Injection containing atropine sulfate monohydrate 600 micrograms in 1 mL  Injection  Atropine Injection (Bridgewest)  (a) between 1 April 2025 and 30 September 2025—6 months stock by reference to usual PBS demand of Atropine Injection (Pfizer)
                                                                                                                                (b) between 1 October 2025 and 31 March 2026—6 months stock by reference to usual PBS demand of both Atropine Injection (Pfizer) and Atropine Injection (Bridgewest) added together
                                                                                                                                (c) after 31 March 2026—6 months stock by reference to usual PBS demand